Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. The company is headquartered in Secaucus, New Jersey and currently employs 45,000 full-time employees. The firm provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. The company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. The company offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The company also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Follow-Up Questions
What is Quest Diagnostics Inc (DGX)'s P/E Ratio?
The P/E ratio of Quest Diagnostics Inc is 23.6344
Who is the CEO of Quest Diagnostics Inc?
Mr. James Davis is the Chairman of the Board of Quest Diagnostics Inc, joining the firm since 2013.
What is the price performance of DGX stock?
The current price of DGX is $178.04, it has increased 0% in the last trading day.
What are the primary business themes or industries for Quest Diagnostics Inc?
Quest Diagnostics Inc belongs to Health Care industry and the sector is Health Care
What is Quest Diagnostics Inc market cap?
Quest Diagnostics Inc's current market cap is $19.9B
Is Quest Diagnostics Inc a buy, sell, or hold?
According to wall street analysts, 19 analysts have made analyst ratings for Quest Diagnostics Inc, including 6 strong buy, 6 buy, 12 hold, 0 sell, and 6 strong sell